Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01997463 · ClinicalTrials.gov registry record · Phase 4
Supervised Asthma Medication in Schools (SAMS)
A Phase 4 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 4
- Development phase
- 442
- Enrollment target
NCT01997463: Completed Phase 4 study, sponsored by University of Arizona.
NCT01997463 is a Phase 4 study that has completed, run by University of Arizona. The registered enrollment target is 442 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01997463, a Phase 4 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 442 participants
- Enrollment target
Study Summary
The investigators hypothesize that school-based, direct supervision of daily controller therapy will result in more effective asthma control, as assessed by the Asthma Control Questionnaire than usual care. Additionally, as the result of enhanced asthma control and resulting decrease in health care utilization, school-based, direct supervision of daily controller therapy will result in lower cost per quality-adjusted life year (QALY) gained than usual care.
Primary Outcome
An ACQ score of \> 1.5 means asthma is not well controlled. An ACQ score of \<= 1.5 means asthma is well controlled. Missing ACQ score = number of participants not administered an ACQ
Interventions
- DRUG Supervised asthma therapy in schools
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-06 |
| Phase | Phase 4 |
What the finished NCT01997463 record still lists
NCT01997463 is an interventional study that assigns participants to a tested intervention. The registered 442 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 1 intervention - of which Supervised asthma therapy in schools is the first listed.
NCT01997463 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01997463 about?
NCT01997463 is a clinical study titled "Supervised Asthma Medication in Schools (SAMS)". The investigators hypothesize that school-based, direct supervision of daily controller therapy will result in more effective asthma control, as assessed by the Asthma Control Questionnaire than usual care. Additionally, as the result of enhanced asthma control and resulting decrease in health care ...
What is the current status of trial NCT01997463?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 442 participants. The study started on 2014-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01997463?
The interventions under investigation include: Supervised asthma therapy in schools (DRUG).
Who is sponsoring clinical trial NCT01997463?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01997463's enrollment target sits among peer trials
442 190th of 2000 higher than 1,811 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
- NCT06659029 · 442 participants
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia